Results 201 to 210 of about 167,485 (300)
Person Re-Identification Using Local Relation-Aware Graph Convolutional Network. [PDF]
Lian Y +5 more
europepmc +1 more source
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
A CNN-RNN Siamese framework with multi-level aggregation for video-based person re-identification. [PDF]
Wang YK, Pan TM, Sun CP.
europepmc +1 more source
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Dynamic adaptive synergistic attention network for visible-infrared person re-identification. [PDF]
Sha L, Cheng S, Liu S.
europepmc +1 more source
Vision Transformer with hierarchical structure and windows shifting for person re-identification. [PDF]
Zhang Y, Hou W.
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Multi-Aligned and Multi-Scale Augmentation for Occluded Person Re-Identification. [PDF]
Jiang X, Yuan X, Yang X.
europepmc +1 more source
Person Re-Identification Based on Contour Information Embedding. [PDF]
Chen H, Zhao Y, Wang S.
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source

